The Latest Headlines at American Banking News
National Bank Financial Reaffirms “Outperform Spec Under Weight” Rating for Green Impact Partners (CVE:GIP)
Green Impact Partners (CVE:GIP)‘s stock had its “outperform spec under weight” rating reissued by stock analysts at National Bank Financial in a report released on Monday. National Bank Financial also issued estimates... More of this article »
Brokers Offer Predictions for aTyr Pharma, Inc.’s Q1 2022 Earnings (NASDAQ:LIFE)
aTyr Pharma, Inc. (NASDAQ:LIFE) – Analysts at Piper Sandler issued their Q1 2022 EPS estimates for aTyr Pharma in a research report issued on Tuesday, September 21st. Piper Sandler analyst E. Tenthoff anticipates that the... More of this article »
Q4 2021 EPS Estimates for United Rentals, Inc. (NYSE:URI) Boosted by KeyCorp
United Rentals, Inc. (NYSE:URI) – Stock analysts at KeyCorp raised their Q4 2021 earnings per share (EPS) estimates for United Rentals in a research note issued to investors on Tuesday, September 21st. KeyCorp analyst K.... More of this article »
Relay Medical’s (RYMDF) “Buy” Rating Reaffirmed at Litchfield Hills Research
Relay Medical (OTCMKTS:RYMDF)‘s stock had its “buy” rating reissued by investment analysts at Litchfield Hills Research in a research note issued to investors on Monday, Zacks.com reports. Shares of RYMDF opened at... More of this article »
Valvoline Inc. (NYSE:VVV) Forecasted to Post Q1 2022 Earnings of $0.47 Per Share
Valvoline Inc. (NYSE:VVV) – Analysts at Jefferies Financial Group issued their Q1 2022 EPS estimates for Valvoline in a note issued to investors on Wednesday, September 22nd. Jefferies Financial Group analyst L. Alexander... More of this article »
Marinus Pharmaceuticals, Inc. Expected to Post FY2021 Earnings of ($2.09) Per Share (NASDAQ:MRNS)
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) – Research analysts at Truist Securiti increased their FY2021 EPS estimates for Marinus Pharmaceuticals in a research note issued to investors on Monday, September 20th. Truist... More of this article »
William Blair Brokers Decrease Earnings Estimates for BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) – Equities researchers at William Blair cut their Q4 2021 EPS estimates for shares of BioDelivery Sciences International in a research note issued to investors on Wednesday,... More of this article »
Jefferies Financial Group Analysts Lift Earnings Estimates for HUTCHMED (China) Limited (NASDAQ:HCM)
HUTCHMED (China) Limited (NASDAQ:HCM) – Stock analysts at Jefferies Financial Group lifted their FY2021 earnings estimates for shares of HUTCHMED in a research note issued to investors on Monday, September 20th. Jefferies... More of this article »
FY2021 EPS Estimates for Henkel AG & Co. KGaA (OTCMKTS:HENKY) Decreased by Analyst
Henkel AG & Co. KGaA (OTCMKTS:HENKY) – Jefferies Financial Group reduced their FY2021 earnings per share (EPS) estimates for Henkel AG & Co. KGaA in a research note issued on Wednesday, September 22nd. Jefferies... More of this article »
FY2021 Earnings Forecast for Genmab A/S (NASDAQ:GMAB) Issued By Truist Securiti
Genmab A/S (NASDAQ:GMAB) – Truist Securiti cut their FY2021 earnings per share estimates for Genmab A/S in a report issued on Tuesday, September 21st. Truist Securiti analyst A. Goonewardene now anticipates that the company... More of this article »
Seaport Res Ptn Analysts Reduce Earnings Estimates for H.B. Fuller (NYSE:FUL)
H.B. Fuller (NYSE:FUL) – Research analysts at Seaport Res Ptn decreased their Q1 2022 earnings estimates for H.B. Fuller in a research note issued on Tuesday, September 21st. Seaport Res Ptn analyst M. Harrison now forecasts... More of this article »
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Forecasted to Post Q4 2021 Earnings of $0.18 Per Share
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) – Analysts at William Blair lowered their Q4 2021 earnings estimates for Eagle Pharmaceuticals in a research report issued to clients and investors on Wednesday, September 22nd. William... More of this article »
Q4 2021 Earnings Forecast for Lennar Co. (NYSE:LEN) Issued By Wedbush
Lennar Co. (NYSE:LEN) – Equities research analysts at Wedbush cut their Q4 2021 earnings per share estimates for Lennar in a research note issued on Tuesday, September 21st. Wedbush analyst J. Mccanless now anticipates that... More of this article »